Pain: Substance Abuse Issues in the Treatment of Pain

  • Howard A. Heit
  • Arthur G. Lipman

About 50 million Americans suffer from chronic pain [1]. As our population continues to age, this number is likely to grow, yet unfortunately, pain continues to be undertreated and poorly treated. Forty to 60% of people with severe pain in the context of life-limiting illnesses have difficulty getting their pain adequately treated [2, 3, 4]. Lost productive time and cost due to common pain conditions in the United States affects 13% of the total workforce and costs the nation $61.2 billion per year [5].

Millions of persons with pain from chronic diseases such as arthritis, diabetes, headaches, and muscle disorders suffer and have difficulty finding and paying for qualified professionals willing to help them gain access to the medicines, physical and psychological therapies and surgical/anesthetic interventions that can help them lead higher quality and more productive lives.

Chronic pain serves no useful purpose [6] once the underlying cause has been identified. It is no longer a...


High Performance Liquid Chromatography Pain Management Pain Patient Control Substance Chronic Pain Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Verhaak PFM, Kerssens JJ, Dekker J, Sorbi MJ, Bensing JM. Prevalence of chronic benign pain disorder among adults: A review of the literature. Pain, 1998, 77:231–239.CrossRefPubMedGoogle Scholar
  2. 2.
    Glajchen M, Fitzmartin RD, Blum D, et al. Psychosocial barriers to cancer pain relief. Cancer Practice, 1995, 3(2):76–82.PubMedGoogle Scholar
  3. 3.
    Ramer L, Richardson JL, Cohen MZ, et al. Multimeasure pain assessment in an ethnically diverse group of patients with cancer. Journal of Transcultural Nursing, 1999, 10(2):94–101.CrossRefPubMedGoogle Scholar
  4. 4.
    Ward SE, Goldberg N, Miller-McCoulry V, et al. Patient-related barriers to management of cancer pain. Pain, 1993, 52:319–324.CrossRefPubMedGoogle Scholar
  5. 5.
    Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R Lost Productive Time and Cost Due to Common Pain Conditions in the US Workforce. JAMA, 2003, 290:2443–2454.41.CrossRefPubMedGoogle Scholar
  6. 6.
    Oaklander, A., The pathology of pain. Neuroscientist, 1999, 5(5):302–310.CrossRefGoogle Scholar
  7. 7.
    Morgan JP. American opiophobia: customary underutilization of opioid analgesics. Advances in Alcohol & Substance Abuse, 1985, 5:163–73.Google Scholar
  8. 8.
    Pohl M. Pain. In Special Populations. 3rd ed. Principles of Addiction Medicine, Graham A et al, editors,Chevy Chase MD, American Society of Addiction Medicine, 2003.Google Scholar
  9. 9.
    Glajchen, M, Chronic pain: treatment barriers and strategies for clinical practice. Journal of American Board of Family Practice, 2001, 14(3):211–8.Google Scholar
  10. 10.
    Wise, R.A., Addiction becomes a brain disease. Neuron, 2000, 26(1): p. 27–33.CrossRefPubMedGoogle Scholar
  11. 11.
    Acute Pain Management Guideline Panel. Acute Pain Management: Operative or Medical Procedures and Trauma; Clinical Practice Guideline. AHCPR Publication Number 92-0032, Rockville MD, Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Service, 1992.Google Scholar
  12. 12.
    Jacox A, Carr DB, Payne R, et al. Management of Cancer Pain. Clinical Practice Guideline. AHCPR Publication Number 94-0592, Rockville MD. Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Service, 1994.Google Scholar
  13. 13.
    Rosenblum A, Joseph H, Fong C, et al. Prevalence and characteristics of chronic pain among chemicallydependent patients in methadone maintenance and residential treatment facilities. JAMA, 2003, 289(18):2370–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Savage SR. Long-term opioid therapy: assessment of consequences and risks. Journal of Pain and Symptom Management, 1996, 11(5):274–86.CrossRefPubMedGoogle Scholar
  15. 15.
    Wassan AD, Correll DJ, Kissin I, O’Shea S, Jamison RN. Iatrogengenic addiction inpatients treated for acute or subacute pain. Journal of Opioid Management, 2006, 2(1): Jan./Feb.:16–21Google Scholar
  16. 16.
    Passik SD, Weinreb HJ. Managing chronic nonmalignant pain: overcoming obstacles to the use of opioids. Advances in Therapy, 2000, 17(2):70–83.CrossRefPubMedGoogle Scholar
  17. 17.
    Compton, P. and G. Gebhart, The Neurophysiology of Pain and Interfaces with Addiction, in Principles of Addiction Medicine, A. Graham, et al., Editors. 2003, American Society of Addiction Medicine: Chevy Chase, MD. pp. 1385–1404.Google Scholar
  18. 18.
    Hoffman NG, Chang AJ, Lewis DC. Medical student attitudes toward drug addiction policy. Journal of Addictive Diseases, 2000, 19(3):1–12.CrossRefGoogle Scholar
  19. 19.
    Heit HA. Addiction, physical dependence, and tolerance: precise definitions to help clinicians evaluate and treat chronic pain patients. Journal of Pain & Palliative Care Pharmacotherapy, 2003, 17(1):15–29.Google Scholar
  20. 20.
    Battin MP, Luna E, Lipman AG et al. Drugs and Justice: Seeking a Consistent, Coherent, Comprehensive View. NY, Oxford University Press, 2007.Google Scholar
  21. 21.
    Heit HA, Gourlay D. Chronic Pain and Addiction. In Chronic Abdominal and Visceral Pain: Theory and Practice. Pasricha PJ, Willis WD, Gebhart GF, editors, NY. Taylor and Francis, 2006.Google Scholar
  22. 22.
    Gourlay D, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Medicine, 2005, 6(2):107–12.CrossRefPubMedGoogle Scholar
  23. 23.
    American Academy of Pain Medicine, American Pain Society, and American Society of Addiction Medicine. Definitions Related to the Use of Opioids for the Treatment of Pain, Glenview, IL, American Academy of Pain Medicine, 2001.Google Scholar
  24. 24.
    SR Savage, DE Joranson, EC Covington, SH Schnoll, HA Heit, AM Gilson. Definitions Related to the Medical Use of Opioids: Evolution Towards Universal Agreement. Journal of Pain and Symptom Management, 2003, 26(1):655–67.CrossRefPubMedGoogle Scholar
  25. 25.
    Weissman DE, Haddox JD. Opioid pseudoaddiction – an iatrogenic syndrome. Pain, 1989, 36(3):363–6.CrossRefPubMedGoogle Scholar
  26. 26.
    Pappagallo M., The concept of pseudotolerance to opioids. Journal of Pharmaceutical Care in Pain and Symptom Control, 1998, 6:95–8.CrossRefGoogle Scholar
  27. 27.
    Lipman AG, Jackson KC. Opioids. In Warfield C, Bajwa Z, editors, Principles and Practice of Pain Management, 2nd edition, New York, McGraw Hill, 2003.Google Scholar
  28. 28.
    Fakata KL, Lipman AG. Opioid Bowel Dysfunction in Acute and Chronic Non-malignant Pain. In Yuan S-H, editor, Opioid Bowel Dysfunction, Binghamton NY, Haworth Medical Press, 2004.Google Scholar
  29. 29.
    Diagnostic and Statistical Manual of Mental Disorders – Text Revised, 4th edition, Washington DC, American Psychiatric Association, 2000.Google Scholar
  30. 30.
    Heit HA, Gourlay D. Urine drug testing in pain medicine. Journal of Pain and Symptom Management, 2004, 27(3):260–7.CrossRefPubMedGoogle Scholar
  31. 31.
    Gourlay D, Heit HA, Caplan YH. Urine Drug Testing in Primary Care: Dispelling the Myths & Designing Strategies. San Francisco, California Academy of Family Physicians, 2006.Google Scholar
  32. 32.
    Passik SD, Schreiber J, Kirsh KL, Portenoy RK. A chart review of the ordering and documentation of urine toxicology screens in a cancer center: do they influence patient management? Journal of Pain and Symptom Management, 2000, 19:40–4.CrossRefPubMedGoogle Scholar
  33. 33.
    Caplan YH, Goldberger BA. Alternative specimens for workplace drug testing. Journal of Analytical Toxicology, 2001, 25:396–399.PubMedGoogle Scholar
  34. 34.
    Conigliaro C, Reyes CR, Schultz JS. Principles of screening and early intervention. In: Graham AW, Schultz TK, Mayo-Smith M, Ries RK, Wilford BB, eds. Principles of addiction medicine, third edition. Chevy Chase, MD: American Society of Addiction Medicine, 2003, 323–1Google Scholar
  35. 35.
    Vandevenne M, Vandenbussche H, Verstraete A. Detection time of drugs of abuse in urine. Acta Clinica Belgica, 2000, 55:323–333.PubMedGoogle Scholar
  36. 36.
    Cook JD, Caplan YH, LoDico CP, Bush DM. The characterization of human urine for specimen validity determination in workplace drug testing: a review. Journal of Analytical Toxicology, 2000, 24:579–588.PubMedGoogle Scholar
  37. 37.
    Casavant MJ. Urine drug screening in adolescents. Pediatric Clinics of North America, 2002, 49:317–327.CrossRefPubMedGoogle Scholar
  38. 38.
    Huestis MA, Mitchell JM, Cone EJ. Detection times of marijuana metabolites in urine by immunoassay and GC–MS. Journal of Analytical Toxicology, 1995, 19:443–44.PubMedGoogle Scholar
  39. 39.
    Simpson D, Braithwaite RA, Jarvie DR, et al. Screening for drugs of abuse (II): cannabinoids, lysergic acid diethylamide, buprenorphine, methadone, barbiturates, benzodiazepines and other drugs. Annals of Clinical Biochemistry, 1997, 34:460–510.PubMedGoogle Scholar
  40. 40.
    Shults TF, St. Clair, S. The Medical Review Officer Handbook. 7th ed. Research Triangle Park NC. Quadrangle Research, 1999.Google Scholar
  41. 41.
    MROALERT November 6 Vol. XVII; No. 9(1–4)Google Scholar
  42. 42.
    American Academy of Pain Management, American Pain Society. The use of opioids for the treatment of chronic pain. Consensus Statement, 1996.
  43. 43.
    Fishman SM, Bandman TB, Edwards A, et al. The opioid contract in the management of chronic pain. Journal of Pain and Symptom Management, 1999, 18:27–37.CrossRefPubMedGoogle Scholar
  44. 44.
    Heit HA. Creating and Implementing Opioid Agreements. Disease Management Digest, 2003, 7(1):2–3, in: Care Management, 2003, 9Google Scholar
  45. 45.
    Passik SD, Heit HA, Kirsh KL. Reality and Responsibility: A Commentary on the Treatment of Pain and Suffering in a Drug-Using Society. Journa of Opioid Management, 2006, 2(3):1–5.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Assistant Clinical Professor of MedicineGeorgetown University School of Medicine

Personalised recommendations